UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and ...

Ben Askren recently underwent a double lung transplant after facing severe complications that threatened his life. Unfortunately, the veteran fighter’s health insurance failed to cover the ...

Then someone started snitching Close encounter with Great White shark caught on camera This NC town is ‘on the rebound' - and ranks among nation's best places to visit ...

Charlie Kirk discussed the future of the youth conservative movement at Turning Point's Student Action Summit this week and warned of Zohran Mamdani's appeal if the GOP fails to deliver.

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial ...

The GEICAM Spanish Breast Cancer Group conducted the phase III PEARL clinical trial comparing palbociclib + ET to single-agent capecitabine in postmenopausal women with AI-resistant HR+/HER2– MBC. 48 ...

Former White Sox pitcher Bobby Jenks, who brought the team to victory at the 2005 World Series, died after a battle with stage 4 stomach cancer.

Former Major League Baseball closer Bobby Jenks has died at the age of 44 after a battle with a terminal form of stomach cancer, the Chicago White Sox announced on Saturday.

Bobby Jenks, a relief pitcher for the 2005 World Series champion Chicago White Sox team, has died at 44 after a battle with stomach cancer, the team announced Saturday.

Former Chicago White Sox closer Bobby Jenks died Friday after a battle with Stage 4 adenocarcinoma, a form of stomach cancer. Jenks was 44 years old.

WASHINGTON, D.C. — Today, President Donald Trump signed into law a bill that “defunds” Planned Parenthood, decimating abortion access and blocking more than a million patients from accessing cancer ...

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.